InvestSMART

Radiopharm Theranostics Limited (ASX: RAD) - Announcements

- Current share price for RAD : $0.010

ASX company news and announcements for Radiopharm Theranostics Limited (RAD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Radiopharm Theranostics Limited (RAD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Radiopharm Theranostics Limited (RAD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Radiopharm Theranostics Limited (RAD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$43 Notice Under Section 708A 15 Dec 2023 5:00PM $0.069 $0.010 fallen by 85.51%
$43 Application for quotation of securities - RAD 15 Dec 2023 4:50PM $0.069 $0.010 fallen by 85.51%
$43 Application for quotation of securities - RAD 8 Dec 2023 10:57AM $0.074 $0.010 fallen by 86.49%
$43 Completion of Entitlement Offer 8 Dec 2023 10:57AM $0.074 $0.010 fallen by 86.49%
$43 Change of Director's Interest Notice - PH IT RC 7 Dec 2023 1:55PM $0.075 $0.010 fallen by 86.67%
$43 Notification regarding unquoted securities - RAD 1 Dec 2023 5:14PM $0.074 $0.010 fallen by 86.49%
$43 Application for quotation of securities - RAD 24 Nov 2023 9:03AM $0.074 $0.010 fallen by 86.49%
$43 Amended Constitution 22 Nov 2023 6:00PM $0.078 $0.010 fallen by 87.18%
$43 Radiopharm receives $4.85M R&D tax incentive 21 Nov 2023 9:54AM $0.075 $0.010 fallen by 86.67%
$43 Update - Proposed issue of securities - RAD 21 Nov 2023 8:50AM $0.075 $0.010 fallen by 86.67%
$43 Entitlement Offer closing date extended to 1 December 2023 21 Nov 2023 8:40AM $0.075 $0.010 fallen by 86.67%
$43 Notification of Release of Shares from Escrow 16 Nov 2023 4:33PM $0.075 $0.010 fallen by 86.67%
$43 Results of Annual General Meeting 16 Nov 2023 12:13PM $0.078 $0.010 fallen by 87.18%
$43 Presentation to Annual General Meeting 16 Nov 2023 8:41AM $0.079 $0.010 fallen by 87.34%
$43 Bell Potter Healthcare Conference Presentation 15 Nov 2023 10:01AM $0.076 $0.010 fallen by 86.84%
$43 Entitlement Offer Documents 8 Nov 2023 8:37AM $0.074 $0.010 fallen by 86.49%
$43 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2023 10:27AM $0.080 $0.010 fallen by 87.50%
$43 Entitlement Offer cleansing notice under section 708AA 31 Oct 2023 10:20AM $0.080 $0.010 fallen by 87.50%
$43 Proposed issue of securities - RAD 31 Oct 2023 9:54AM $0.100 $0.010 fallen by 90%
$43 Investor webinar 31 Oct 2023 9:36AM $0.100 $0.010 fallen by 90%
$43 Proposed issue of securities - RAD 31 Oct 2023 9:26AM $0.100 $0.010 fallen by 90%
$43 Investor Presentation - Entitlement Offer 31 Oct 2023 9:22AM $0.100 $0.010 fallen by 90%
$43 Entitlement Offer to raise approximately $10 million 31 Oct 2023 9:06AM $0.100 $0.010 fallen by 90%
$43 Notice of Annual General Meeting/Proxy Form 18 Oct 2023 8:25AM $0.125 $0.010 fallen by 92%
$43 FDA green light for diagnostic Phase 1 pancreatic trial 17 Oct 2023 10:10AM $0.135 $0.010 fallen by 92.59%

276 - 300 of 616 results

Page 12 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.